o-desmethylangolensin has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franke, AA; LaSalle, CD; Reverri, EJ; Steinberg, FM | 1 |
| Mishchuk, DO; Reverri, EJ; Slupsky, CM; Steinberg, FM | 1 |
2 trial(s) available for o-desmethylangolensin and Metabolic Syndrome
| Article | Year |
|---|---|
Soy provides modest benefits on endothelial function without affecting inflammatory biomarkers in adults at cardiometabolic risk.
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Chromatography, Liquid; Cross-Over Studies; Diet; Diet Records; Endothelium; Enzyme-Linked Immunosorbent Assay; Equol; Female; Glycine max; Humans; Inflammation; Isoflavones; Male; Metabolic Syndrome; Middle Aged; Nuts; Oxidative Stress; Risk Factors; Tandem Mass Spectrometry; Vascular Stiffness | 2015 |
Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors.
Topics: Equol; Female; Food; Glycine max; Humans; Inactivation, Metabolic; Isoflavones; Male; Metabolic Syndrome; Metabolomics; Middle Aged; Phenotype; Risk Factors | 2017 |